Literature DB >> 8095499

A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene.

M E Goldsmith1, M J Madden, C S Morrow, K H Cowan.   

Abstract

Basal transcription of the human multidrug resistance (mdr1) promoter was studied by chloramphenicol acetyltransferase (CAT) reporter fusion gene analysis in two parental and doxorubicin-resistant human tumor cell lines. Deletion of mdr1 DNA sequences to -89 relative to the start of transcription (at +1) had little effect on expression. Deletion of nucleotide sequences from -89 to -70, however, resulted in a 5-10-fold reduction in mdrCAT expression. DNase I footprint analysis demonstrated that the region from -85 to -70 was protected from nuclease digestion using nuclear extracts from these cell lines. The sequence between -82 and -73 is perfectly homologous with the 10-base pair Y-box consensus sequence found in the promoters of all major histocompatibility complex class-II (MHC II) genes. The Y-box sequence in MHC II genes is required for accurate and efficient transcription and contains the sequence CCAAT in the reverse orientation (Dorn, A., Durand, B., Marfing, C., Le Meur, M., Benoist, C., and Mathis, D. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 6249-6253). Mutations in the reverse CCAAT sequence of the Y-box consensus substantially reduced expression of an mdrCAT vector and eliminated nucleoprotein binding in an electrophoretic mobility shift assay. These results suggest that proteins which bind to the putative Y-box consensus sequence are critical for basal transcriptional regulation of the human mdr1 gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins.

Authors:  Isabelle Gaudreault; David Guay; Michel Lebel
Journal:  Nucleic Acids Res       Date:  2004-01-12       Impact factor: 16.971

2.  Structural and functional analysis of the human Y-box binding protein (YB-1) gene promoter.

Authors:  Y Makino; T Ohga; S Toh; K Koike; K Okumura; M Wada; M Kuwano; K Kohno
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

3.  YB-1, the E2F pathway, and regulation of tumor cell growth.

Authors:  Annette Lasham; Weini Samuel; Helen Cao; Rachna Patel; Reena Mehta; J Lewis Stern; Glen Reid; Adele G Woolley; Lance D Miller; Michael A Black; Andrew N Shelling; Cristin G Print; Antony W Braithwaite
Journal:  J Natl Cancer Inst       Date:  2011-12-28       Impact factor: 13.506

4.  The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.

Authors:  Rajash Pallai; Henry Simpkins; Jianli Chen; Hemant K Parekh
Journal:  Gene       Date:  2010-03-23       Impact factor: 3.688

Review 5.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

6.  Identification and developmental characterization of a novel Y-box protein from Drosophila melanogaster.

Authors:  H A Thieringer; K Singh; H Trivedi; M Inouye
Journal:  Nucleic Acids Res       Date:  1997-12-01       Impact factor: 16.971

7.  Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression.

Authors:  F Kashanchi; J F Duvall; J Dittmer; A Mireskandari; R L Reid; S D Gitlin; J N Brady
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 8.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

9.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

10.  Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.

Authors:  Anna L Stratford; Christopher J Fry; Curtis Desilets; Alastair H Davies; Yong Y Cho; Yvonne Li; Zigang Dong; Isabelle M Berquin; Philippe P Roux; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2008-11-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.